bf/NASDAQ:CFMS_icon.png

COM:CONFORMIS

Conformis

  • Stock

USD

Last Close

2.26

01/09 19:57

Market Cap

17.88M

Beta: -

Volume Today

7.08K

Avg: -

Company Overview

Metric
Company NameConformis, Inc.DePuy Synthes
SymbolCFMS
MSH IDCOM:CONFORMISCOM:DEPUYSYNTHES
MarketSTOCKSPRIVATE
SectorHealthcareHealthcare & Health Services
IndustryMedical - DevicesMedical Technology
CountryUSUS
Stage
Employee Count295
Websiteconformis.comdepuysynthes.com
LinkedIn
Founders

Market Metrics

Metric
Market Cap17.88M
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Financial Performance

Metric
Revenue62.05M
Revenue (LTM)
Revenue (NTM)
Gross Profit23.21M
EBITDA-46.23M
Operating Income-46.28M
Net Income-50.47M
EPS-6.99
Diluted EPS-6.99
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Growth Metrics

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Profitability Ratios

Metric
Gross Profit Margin0.33
Operating Profit Margin-0.71
EBITDA Margin-0.74
Net Profit Margin-0.73
Return on Equity-0.86
Return on Assets-0.61
Return on Capital Employed-0.71

Valuation Multiples

Metric
P/E Ratio-0.40
P/B Ratio0.52
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio0.31
EV Multiple-0.45

Operational Metrics

Metric
Days Sales Outstanding49.87
Days Payables Outstanding34.32
Days Inventory Outstanding182.18
Operating Cycle232.05
Cash Conversion Cycle197.73
Asset Turnover0.84

Cash Flow Metrics

Metric
Operating Cash Flow-50.15M
Free Cash Flow-52.07M
Cash Flow to Debt-1.67
Operating Cash Flow/Sales-0.78
Free Cash Flow Yield-2.61

Balance Sheet Metrics

Metric
Cash & Equivalents48.67M
Accounts Receivable-945K
Inventory18.91M
Goodwill
Debt to Capitalization0.45
Debt to Assets0.39
Current Ratio5.07
Quick Ratio3.15

Efficiency Metrics

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue0.03
R&D to Revenue0.20
SG&A to Revenue0.47